AHR 8-K
American Healthcare REIT, Inc. (AHR)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): |
(Exact name of Registrant as Specified in Its Charter)
(State or Other Jurisdiction |
(Commission File Number) |
(IRS Employer |
||
|
|
|
|
|
|
||||
|
||||
(Address of Principal Executive Offices) |
|
(Zip Code) |
||
Registrant’s Telephone Number, Including Area Code: |
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
|
|
Trading |
|
|
|
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 7.01 Regulation FD Disclosure.
Third Quarter 2026 Distribution
On September 18, 2026, we issued a press release announcing our third quarter 2026 distribution, as further described in Item 8.01 below. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated by reference herein.
The information furnished under this Item 7.01, including Exhibit 99.1, shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.
Item 8.01 Other Events.
On September 18, 2026, our board of directors authorized a distribution to holders of our common stock of record as of the close of business on September 30, 2026, for the quarter commencing on July 1, 2026 and ending on September 30, 2026. The quarterly distribution will be equal to $0.25 per share of our common stock, which is equal to an annualized distribution rate of $1.00 per share. The third quarter distribution will be paid in cash on or about October 16, 2026, only from legally available funds.
Item 9.01 Financial Statements and Exhibits.
Exhibit No. |
|
Description |
|
American Healthcare REIT, Inc. Press Release dated September 18, 2026 |
|
104 |
|
Cover Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
American Healthcare REIT, Inc. |
|
|
|
|
Date: |
September 18, 2026 |
By: |
/s/ Jeffrey T. Hanson |
|
|
|
Name: Jeffrey T. Hanson |
Exhibit 99.1
American Healthcare REIT Declares Third Quarter 2026 Distribution
IRVINE, Calif., September 18, 2026 – American Healthcare REIT, Inc. (NYSE: AHR) announced today that its board of directors has declared a quarterly distribution of $0.25 per share for the quarter ending September 30, 2026. The distribution will be payable in cash on or about October 16, 2026, to all holders of record of its common stock as of the close of business on September 30, 2026.
About American Healthcare REIT, Inc.
American Healthcare REIT, Inc. (NYSE: AHR) is a real estate investment trust that acquires, owns and operates a diversified portfolio of clinical healthcare real estate, focusing primarily on senior housing communities, skilled nursing facilities, and outpatient medical buildings across the United States, and in the United Kingdom and the Isle of Man.
SOURCE American Healthcare REIT, Inc.
Investor Contact:
Alan Peterson
VP, Investor Relations & Finance
(949) 270-9200
Media Contact:
Damon Elder
Spotlight Marketing Communications
(949) 427-1377